About
Kaitlin Kestenberg has served as Chief Operating Officer and Senior Vice President, Compliance since April 2024. She joined ADMA in 2012 as a Clinical Research Manager and advanced through positions of increasing responsibility.
Before joining ADMA she held roles in clinical operations, quality operations and compliance at Acorda Therapeutics and Merck & Co. She holds a B.A. from the State University of New York at Albany and an M.S.J. from Seton Hall University.
Roles
Adma Biologics, Inc.
Chief Operating Officer and Senior Vice President, Compliance · Current role
2012–present
ADMA Biologics
Senior Vice President, Compliance & Project Operations
April 2023-March 2024
ADMA Biologics
Vice President, Compliance & Project Management and Acting Head of Analytical and Process Development
May 2021-March 2023
ADMA Biologics
Vice President, Compliance & Project Management
April 2019-May 2021
ADMA Biologics
Senior Director, Compliance, Project Management & Clinical Operations
January 2018-March 2019
Acorda Therapeutics, Inc.
Clinical operations, quality and compliance
—
Merck & Co. Inc.
Clinical operations, quality and compliance
—
Fixed Compensation
FY 2025Base salary
$575,000
FY2025 base salary
All other compensation
$54,284
401(k) match, medical benefits and life insurance premiums
Performance Compensation
Data from FY 2025Cash incentive
Non-equity incentive plan (annual bonus)
$359,375
Target Opportunity
—
Paid March 2026 for 2025 performance
Stock awards
Stock awards (RSUs)
$1,249,989
Grant date fair value
Option awards
$1,249,999
Grant date fair value
Also at Adma Biologics, Inc.
See how Top Bucket AI works for your firm
Request DemoTop Bucket AI Research
Stay ahead of private markets
Research and market intelligence for private-markets professionals.
✓
You're subscribed.
Thanks for signing up.